Amneal Pharmaceuticals (AMRX) Change in Inventory (2017 - 2026)

Amneal Pharmaceuticals has reported Change in Inventory for 10 years, with the latest figure at $69.2 million in Q2 2026.

• On a quarterly basis, Change in Inventory rose 203.79% year-over-year to $69.2 million in Q2 2026; TTM through Jun 2026 was $175.1 million, a 33.57% increase from a year earlier, with the FY2025 full-year figure at $87.0 million, down 33.33% from the prior year.
• Change in Inventory was $69.2 million for Q2 2026 at Amneal Pharmaceuticals, up from $55.0 million in the prior quarter.
• The five-year high for Change in Inventory was $69.2 million in Q2 2026, with the low at $11.1 million in Q4 2022.
• Average Change in Inventory over 5 years is $31.7 million, with a median of $25.7 million recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Change in Inventory sank 61.18% in 2025, then jumped 314.38% in 2026.
• Over 5 years, Change in Inventory stood at $11.1 million in 2022, then surged by 108.58% to $23.1 million in 2023, then surged by 125.14% to $52.0 million in 2024, then slumped by 61.18% to $20.2 million in 2025, then surged by 242.87% to $69.2 million in 2026.
• The last three Change in Inventory figures came in at $69.2 million (Q2 2026), $55.0 million (Q1 2026), and $20.2 million (Q4 2025), per Business Quant data.